EMA Recommends EU Marketing Authorization for Lilly Weight-Loss Drug
The European Medicines Agency recommended granting EU marketing authorization for Eli Lilly’s once-daily oral weight-loss drug Foundayo.
By Connor HartThe European Medicines Agency has recommended granting a marketing authorization for Eli Lilly's weight-loss drug Foundayo in the European Union.The once-daily oral treatment provides an alternative to other oral and injectable GLP-1 medicines, the agency said Friday. It can be used a…